Developer docs
API playgroundTry for free, no card

Search company profiles

Curelator

Full company profile

uuid02m3hko

Namestring
Curelator
Legal namestring
Curelator, LLC
Websiteurl
curelator.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Curelator is a Cambridge, Massachusetts-based digital health company founded in 2013 that operates the N1-Headache™ platform, a migraine management system combining a mobile application (available on iOS and Android) with a web-based clinician dashboard. The platform enables patients to track headache outcomes, measure therapeutic response in real time, and identify personalized migraine risk factors through what the company characterizes as scientific, factor-by-factor analysis. Curelator serves two customer segments: individuals with migraine seeking to understand personal triggers, and healthcare providers (primarily neurologists) who use the platform to monitor patient outcomes between visits.

The underlying technology appears to be a proprietary data-driven personalization engine, with the company asserting that its technologies, processes, and materials are subject to multiple patents, trademarks, and copyrights issued and pending worldwide. Curelator has cultivated partnerships with prominent neurologists globally and cites clinical studies as evidence supporting the platform's efficacy, positioning N1-Headache™ as an evidence-based tool rather than a generic headache diary.

Curelator operates a subscription-based revenue model with a Premium Subscription tier. Patient acquisition is hybrid: direct-to-consumer via app stores and web, and via the N1-Headache™ Clinician Code program, which enables healthcare providers to grant patients free Premium Subscription access as part of clinical care. The company is privately held as Curelator, LLC, with no disclosed institutional investors, funding rounds, or revenue figures in the available source material.

Short descriptiontext

Curelator is a Cambridge, MA-based digital health company operating the N1-Headache™ mobile and web platform, which helps migraine patients and their clinicians track headache outcomes, measure therapeutic response, and identify personalized migraine risk factors. Revenue is generated through a Premium Subscription tier.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
digital migraine management, headache tracking software, digital therapeutics platform, patient health analytics, migraine risk factors
Industry2 codes
1Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
CodeHLALABAKPrimaryYes
2Headache & Migraine Medicine
CodeHLAKAIAEPrimaryNo
NAICS code1 code
  • Home Health Care Services62161
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Prepackaged Software7372
Product category
Digital Health Software — Migraine Management
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Premium Subscription
TypeSubscription Recurring
Description

Subscription-based model with free Premium Subscription access provided to patients through the N1-Headache Clinician Code program offered by healthcare providers. Tiered access with basic free tier and premium paid features.

n1-headache.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Premium Subscription with Clinician Code access
ModelSubscriptionBilling cadenceMonthly
Notes

Free Premium Subscription access provided to patients through the N1-Headache Clinician Code program offered by healthcare providers.

n1-headache.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 record
1N1-Headache™
Description

Digital migraine management platform that helps patients discover everyday factors affecting migraine risk through a mobile app and web-based dashboard.

n1-headache.com
Core offering1 text field

Curelator operates the N1-Headache™ digital health platform, which combines a mobile application and a web-based dashboard to help migraine patients identify everyday factors affecting their individual migraine risk. The platform offers a free tier alongside a Premium Subscription with enhanced features, and operates a Clinician Code Program that allows healthcare providers to provide free Premium access to their migraine patients for monitoring and therapeutic response measurement.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Curelator offers N1-Headache™, a unified digital health platform for migraine management. The platform comprises a mobile app (available on iOS and Android) and a web-based clinician dashboard that connect patients with their healthcare providers. The platform enables monitoring of individual headache outcomes, real-time measurement of therapeutic response, and identification of personalized migraine risk factors through scientific analysis. Healthcare providers can offer patients free Premium Subscription access via the N1-Headache™ Clinician Code Program.

Product and service1 record
1N1-Headache™ Platform
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Prominent Neurologists (Global)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

N1-Headache's partnerships with prominent neurologists around the world have generated findings that deepen understanding of migraine. These partnerships enable evidence-based personalized management of migraine through clinical studies and research collaborations.

n1-headache.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
1Healint
TypeDirect peer
Description

Healint operates Migraine Buddy, the most widely used consumer migraine tracking app. It is the closest direct peer to N1-Headache — same target patient, same tracking/analysis paradigm, same mobile-first distribution, and similar clinician-facing positioning.

2Big Health
TypeEmerging player
Description

Big Health commercializes digital therapeutics (e.g., Sleepio, Daylight) into payer and clinician channels. Comparable to Curelator in digital health delivery and payer/provider GTM, though focused on insomnia and anxiety rather than migraine.

3Akili Interactive
TypeEmerging player
Description

Akili is a prescription digital therapeutics company with FDA-authorized cognitive therapy apps. It is a relevant emerging peer in the digital therapeutics category and shares Curelator's challenge of driving clinician adoption and payer coverage for software-based therapy.

4AbbVie
TypeBroad incumbent
Description

AbbVie markets Botox for chronic migraine and Ubrelvy. It is a broad incumbent in migraine therapeutics with the neurologist relationships and scale that Curelator must navigate to grow provider adoption.

5Click Therapeutics
TypeEmerging player
Description

Click Therapeutics develops prescription digital therapeutics across neurology and other indications. It is comparable as a software-based, evidence-driven digital therapeutic company pursuing both consumer and clinician/payer channels.

6Theranica
TypeEmerging player
Description

Theranica develops Nerivio, an FDA-cleared digital therapeutic wearable for migraine. It overlaps with Curelator in digital migraine therapeutics and provider-prescribed channels, but competes via a connected device rather than a pure software platform.

7BonTriage
TypeDirect peer
Description

BonTriage provides a clinician-referred digital headache and migraine assessment platform. Comparable to Curelator in targeting the patient–clinician workflow around headache diagnosis and risk factor identification, though more focused on triage than ongoing tracking.

8Eli Lilly
TypeBroad incumbent
Description

Lilly markets Emgality and other CGRP-based migraine therapies and is a broad incumbent in migraine treatment. Comparable as a major counterparty for clinician relationships and as a potential strategic acquirer or partner that could bundle digital tools with its migraine franchise.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Curelator

Digital Health Software — Migraine Managementcurelator.com

Curelator is a Cambridge, MA-based digital health company operating the N1-Headache™ mobile and web platform, which helps migraine patients and their clinicians track headache outcomes, measure therapeutic response, and identify personalized migraine risk factors. Revenue is generated through a Premium Subscription tier.

What Curelator does

Curelator is a Cambridge, Massachusetts-based digital health company founded in 2013 that operates the N1-Headache™ platform, a migraine management system combining a mobile application (available on iOS and Android) with a web-based clinician dashboard. The platform enables patients to track headache outcomes, measure therapeutic response in real time, and identify personalized migraine risk factors through what the company characterizes as scientific, factor-by-factor analysis. Curelator serves two customer segments: individuals with migraine seeking to understand personal triggers, and healthcare providers (primarily neurologists) who use the platform to monitor patient outcomes between visits.

The underlying technology appears to be a proprietary data-driven personalization engine, with the company asserting that its technologies, processes, and materials are subject to multiple patents, trademarks, and copyrights issued and pending worldwide. Curelator has cultivated partnerships with prominent neurologists globally and cites clinical studies as evidence supporting the platform's efficacy, positioning N1-Headache™ as an evidence-based tool rather than a generic headache diary.

Curelator operates a subscription-based revenue model with a Premium Subscription tier. Patient acquisition is hybrid: direct-to-consumer via app stores and web, and via the N1-Headache™ Clinician Code program, which enables healthcare providers to grant patients free Premium Subscription access as part of clinical care. The company is privately held as Curelator, LLC, with no disclosed institutional investors, funding rounds, or revenue figures in the available source material.

Curelator firmographics

Firmographics
Name
Curelator
Legal name
Curelator, LLC
Website
https://curelator.com
Company type
Private
Founded year
2013
Operating status
Operating
Short description
Curelator is a Cambridge, MA-based digital health company operating the N1-Headache™ mobile and web platform, which helps migraine patients and their clinicians track headache outcomes, measure therapeutic response, and identify personalized migraine risk factors. Revenue is generated through a Premium Subscription tier.
Ownership category
akta.pro rank

Curelator industry classification

Industry
Product category
Digital Health Software — Migraine Management
NAICS
Home Health Care Services (62161)
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)
akta.pro primary industry
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
akta.pro secondary industry
Headache & Migraine Medicine (HLAKAIAE)

Keywords

  • Digital migraine management
  • Headache tracking software
  • Digital therapeutics platform
  • Patient health analytics
  • Migraine risk factors

Where Curelator is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Markets served

Curelator business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Premium Subscription: Subscription-based model with free Premium Subscription access provided to patients through the N1-Headache Clinician Code program offered by healthcare providers. Tiered access with basic free tier and premium paid features.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyPremium Subscription with Clinician Code access

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Curelator product offering

Product offering

Core offering

Curelator operates the N1-Headache™ digital health platform, which combines a mobile application and a web-based dashboard to help migraine patients identify everyday factors affecting their individual migraine risk. The platform offers a free tier alongside a Premium Subscription with enhanced features, and operates a Clinician Code Program that allows healthcare providers to provide free Premium access to their migraine patients for monitoring and therapeutic response measurement.

Product overview

Curelator offers N1-Headache™, a unified digital health platform for migraine management. The platform comprises a mobile app (available on iOS and Android) and a web-based clinician dashboard that connect patients with their healthcare providers. The platform enables monitoring of individual headache outcomes, real-time measurement of therapeutic response, and identification of personalized migraine risk factors through scientific analysis. Healthcare providers can offer patients free Premium Subscription access via the N1-Headache™ Clinician Code Program.

Differentiator

Problem solved

Functional benefit

Brands

  • N1-Headache™: Digital migraine management platform that helps patients discover everyday factors affecting migraine risk through a mobile app and web-based dashboard.

Products and services

  • N1-Headache™ Platform

Companies that use Curelator

Customer profile

Segments2 records

Ideal customer profiles2 records

Curelator technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Curelator partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Prominent Neurologists (Global)coreStrategic or Co-development PartnerN1-Headache's partnerships with prominent neurologists around the world have generated findings that deepen understanding of migraine. These partnerships enable evidence-based personalized management of migraine through clinical studies and research collaborations.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Curelator competitors and assessment

Company assessment

Direct peers

  • Healint: Healint operates Migraine Buddy, the most widely used consumer migraine tracking app. It is the closest direct peer to N1-Headache — same target patient, same tracking/analysis paradigm, same mobile-first distribution, and similar clinician-facing positioning.
  • BonTriage: BonTriage provides a clinician-referred digital headache and migraine assessment platform. Comparable to Curelator in targeting the patient–clinician workflow around headache diagnosis and risk factor identification, though more focused on triage than ongoing tracking.

Emerging players

  • Big Health: Big Health commercializes digital therapeutics (e.g., Sleepio, Daylight) into payer and clinician channels. Comparable to Curelator in digital health delivery and payer/provider GTM, though focused on insomnia and anxiety rather than migraine.
  • Akili Interactive: Akili is a prescription digital therapeutics company with FDA-authorized cognitive therapy apps. It is a relevant emerging peer in the digital therapeutics category and shares Curelator's challenge of driving clinician adoption and payer coverage for software-based therapy.
  • Click Therapeutics: Click Therapeutics develops prescription digital therapeutics across neurology and other indications. It is comparable as a software-based, evidence-driven digital therapeutic company pursuing both consumer and clinician/payer channels.
  • Theranica: Theranica develops Nerivio, an FDA-cleared digital therapeutic wearable for migraine. It overlaps with Curelator in digital migraine therapeutics and provider-prescribed channels, but competes via a connected device rather than a pure software platform.

Broad incumbents

  • AbbVie: AbbVie markets Botox for chronic migraine and Ubrelvy. It is a broad incumbent in migraine therapeutics with the neurologist relationships and scale that Curelator must navigate to grow provider adoption.
  • Eli Lilly: Lilly markets Emgality and other CGRP-based migraine therapies and is a broad incumbent in migraine treatment. Comparable as a major counterparty for clinician relationships and as a potential strategic acquirer or partner that could bundle digital tools with its migraine franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Curelator social profiles

Digital presence

Curelator financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Curelator leadership team

Management profile

Number of profiles

Curelator funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Curelator M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curelator

What does Curelator do?

Curelator operates the N1-Headache™ digital health platform, which combines a mobile application and a web-based dashboard to help migraine patients identify everyday factors affecting their individual migraine risk. The platform offers a free tier alongside a Premium Subscription with enhanced features, and operates a Clinician Code Program that allows healthcare providers to provide free Premium access to their migraine patients for monitoring and therapeutic response measurement.

Is Curelator a public or private company?

Curelator is a private company. It is classified as unknown and is currently operating.

When was Curelator founded?

Curelator was founded in 2013.

Where is Curelator based?

Curelator is headquartered in Cambridge, United States, in the North America region.

How does Curelator make money?

One revenue line is on record: premium Subscription.

Who are Curelator's main competitors?

Direct peers on record are Healint and BonTriage. Emerging players are Big Health, Akili Interactive, Click Therapeutics and Theranica. Broad incumbents are AbbVie and Eli Lilly.

Does Curelator have an API?

No public API is recorded for Curelator.

What industry is Curelator in?

Curelator's product category is Digital Health Software — Migraine Management. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLAKAIAE, Headache & Migraine Medicine. Its NAICS code is 62161 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNew Study by Curelator Reveals Surprisingly Variable Relationship between Peak Pain Severity and Stress in Individuals with Chronic MigraineCurelator Inc. announced new data from one of the largest longitudinal chronic migraine studies to date, analyzing daily, prospectively collected data from 136 participants across more than 8,200 migraine days over three months using the N1-Headache app. The study found that on average, peak pain severity was higher on days with higher perceived stress, but there was substantial individual variation—some participants showed no relationship while others even experienced lower severity on higher stress days. The findings underscore the need for personalized treatment approaches for migraine patients based on individual trigger patterns.PR NewswireNew Study by the University of Calgary and Curelator Reveals Surprising Lack of Association Between Stress and MigraineA clinical study co-conducted by the University of Calgary and Curelator found that stress is significantly less associated with migraine attacks than previously believed, challenging a long-held medical assumption. The research, the largest stress-migraine study to date with 351 patients and 2,115 migraine episodes over three months, found that only 7.1% of patients had most attacks linked to increased stress, while 76% of attacks occurred with flat or decreasing stress levels. The findings underscore the need for personalized phenotypic analysis and treatment plans rather than population-based approaches.PR NewswireCurelator Headache announces study with NYU Langone Medical Center to examine effectiveness of protective behaviors for migraineurs and post-concussive headache patientsNYU Langone Medical Center is initiating a clinical study using the Curelator Headache digital application to examine whether behavioral treatments and protective behaviors can reduce headache frequency and intensity in patients with migraine and post-concussive headaches. The study will enroll 100 migraine patients and 75 post-concussion headache patients, who will input daily data for 90 days (with optional 90-day extension) while performing relaxation exercises. Curelator Inc., which developed the application, is partnering with NYU Langone for this IRB-approved research, with Dr. Mia Minen serving as principal investigator.PR NewswireCurelator Headache study in Cephalagia shows migraineurs may have "unique" trigger profilesA study published in Cephalalgia journal found that 85% of migraine patients have highly individualized trigger profiles that are unique to each person and not apparent from population-level analysis. The research, conducted using Curelator Headache's N=1 statistical platform on data from 327 patients in the PAMINA study, revealed that factors such as diet and weather—undetectable at the population level—significantly triggered attacks in individual patients. The findings support the need for personalized migraine management approaches rather than generalized one-size-fits-all treatment strategies.